
European Human Genetics Conference 2026
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to European Human Genetics Conference 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
European Human Genetics Conference 2026
Event overview: The European Human Genetics Conference 2026 is one of the most important gatherings for human genetics, genomic medicine, rare disease research, molecular diagnostics, precision medicine, and clinical research professionals in Europe. This event typically attracts a highly specialized audience made up of researchers, clinicians, laboratory leaders, biotech and pharma professionals, diagnostic companies, academic institutions, and healthcare innovation stakeholders.
Event type: Human genetics, genomics, clinical research, molecular diagnostics, rare disease, precision medicine, biotech, healthcare innovation
Estimated attendance: Usually strong international attendance, often several thousand delegates, with a mix of academic, clinical, commercial, and research professionals. The event is considered a high-value B2B and scientific networking environment because the audience is specialized and buyer intent is strong in areas such as lab technology, sequencing, software, data analytics, diagnostics, and research services.
1️⃣ Who attends: Buyers / Attendees
This event is primarily attended by professionals who work in genetics, genomics, healthcare research, diagnostics, and life sciences innovation. It is not a general public expo. The audience is highly specialized and includes both technical decision-makers and commercial buyers.
Main attendee groups:
- Human geneticists and clinical geneticists
- Genomics researchers and principal investigators
- Molecular biologists and bioinformaticians
- Rare disease specialists and translational medicine leaders
- Hospital-based lab directors and diagnostic laboratory managers
- Biotech and pharmaceutical R&D teams
- Genetic counselors and clinical service providers
- University faculty, research institute heads, and postgraduate scientists
- Sequencing platform, assay, and lab technology buyers
- Healthcare data and AI solution buyers
- Medical device and diagnostics business development teams
- Regulatory, reimbursement, and market access professionals in genetics
Buyer value: This is a strong event for selling to institutions and organizations that buy genomics technology, lab consumables, research software, clinical decision support tools, sequencing systems, sample management platforms, and diagnostic services.
2️⃣ Where the show is happening + attendee geographic origin
Show location: The conference is held in Europe, and the exact host city may vary by year depending on the event edition. For targeting purposes, this event should be treated as a Europe-based scientific conference with international pull.
Attendee geographic origin:
- Primarily Europe-based attendees
- Strong participation from the United Kingdom, Germany, France, Italy, Spain, Netherlands, Belgium, Switzerland, Nordics, and Central/Eastern Europe
- International delegates from North America, Asia-Pacific, Middle East, and other research-heavy regions
- Large academic and clinical representation from hospitals, universities, and research institutes across Europe
Best geographic targeting: If your client sells B2B products into life sciences, Europe is the primary target region, but the event also offers value for global companies with EMEA teams, regional distributors, and European market-entry teams.
3️⃣ Audience reach
Reach type: Global with a strong European core
This conference has a distinctly international scientific audience. While Europe is the center of gravity, the content and speaker quality typically attract global attention from researchers, lab technology providers, and clinical genomics stakeholders. For lead generation, it is a premium event because the attendee mix is decision-rich rather than volume-rich.
4️⃣ Sample buyer company names + websites
Below are sample buyer companies that are well aligned with this event. These are not random names; they represent organizations that are likely to have a direct interest in human genetics, genomics, diagnostics, sequencing, bioinformatics, lab automation, or clinical research.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Illumina | illumina.com | Director, EMEA Sales / Genomics Partnerships Manager / Product Marketing Manager | Leading sequencing and genomics company; highly aligned with genetics and clinical genomics buyers. |
| 2 | Thermo Fisher Scientific | thermofisher.com | Global Marketing Manager, Genomics / Business Development Manager / Lab Solutions Lead | Strong fit for sequencing, PCR, lab consumables, diagnostics, and research tools. |
| 3 | QIAGEN | qiagen.com | Commercial Director, EMEA / Market Development Manager / Clinical Genomics Lead | Directly serves molecular diagnostics, sample prep, and genomic workflow buyers. |
| 4 | Oxford Nanopore Technologies | nanoporetech.com | Regional Sales Director / Field Application Manager / Clinical Strategy Lead | Highly relevant for long-read sequencing and research-to-clinic genomics adoption. |
| 5 | Eurofins Genomics | eurofinsgenomics.eu | Business Development Director / Operations Manager / Lab Services Lead | Large genomics service provider with strong research and clinical customer overlap. |
| 6 | Agilent Technologies | agilent.com | Genomics Product Manager / Sales Director / Application Specialist Lead | Offers instrumentation, analytics, and workflow solutions used in genetics labs. |
| 7 | Roche Diagnostics | roche.com | Head of Molecular Diagnostics / Commercial Excellence Manager / Business Unit Director | Major diagnostics leader with direct relevance to clinical genetics and precision medicine. |
| 8 | BGI Genomics | bgi.com | International Business Manager / Genomics Solutions Lead / Regional Sales Director | Large-scale genomics services and sequencing provider with global reach. |
| 9 | PerkinElmer | perkinelmer.com | Life Sciences Sales Manager / Genomics Product Specialist / Market Development Manager | Relevant for screening, diagnostics, and laboratory workflow buyers. |
| 10 | Novogene | novogene.com | Business Development Director / Research Services Lead / Scientific Account Manager | Strong fit for sequencing services, omics, and research collaborations. |
| 11 | MedGenome | medgenome.com | Director, Clinical Genomics / International Sales Head / Partnerships Manager | Clinical genomics and rare disease focus makes it a natural attendee fit. |
| 12 | Congenica | congenica.com | Commercial Lead / Product Manager, Clinical Decision Support / Partnerships Director | Genomic interpretation and clinical software buyer profile aligns well. |
| 13 | SOPHiA GENETICS | sophiagenetics.com | Regional Sales Manager / Clinical Solutions Director / Market Access Lead | Strong buyer fit for AI-driven genomic analysis and clinical workflow solutions. |
| 14 | Starlab Group | starlabgroup.com | Life Sciences Sales Manager / Distribution Manager / Product Specialist | Supplies lab consumables and equipment to genetics and molecular biology labs. |
| 15 | Oxford University Hospitals NHS Foundation Trust | ouh.nhs.uk | Head of Genomic Medicine / Laboratory Director / Clinical Lead | Major hospital system with genetics, diagnostics, and precision medicine needs. |
Top 5 best samples to send first: Illumina, Thermo Fisher Scientific, QIAGEN, Oxford Nanopore Technologies, Roche Diagnostics. These companies represent the strongest combination of demand, budget, and event relevance.
5️⃣ Job profiles, industries & event type
Best job profiles to target:
- Director of Genomics
- Head of Molecular Diagnostics
- Clinical Geneticist
- Genomics Product Manager
- Business Development Manager, Life Sciences
- Regional Sales Director, EMEA
- Lab Director / Laboratory Manager
- Scientific Affairs Manager
- Bioinformatics Lead
- Research Program Director
- Precision Medicine Lead
- Clinical Strategy Manager
- Market Access Manager
- Partnerships Director
- Application Specialist, Genomics
- Medical Science Liaison
Best industry filters to use:
- Biotechnology
- Pharmaceuticals
- Medical Devices
- Research
- Hospital & Health Care
- Higher Education
- Education Management
- Information Technology & Services
- Computer Software
- Health, Wellness & Fitness
- Management Consulting
- Market Research
- Medical Practice
- Biotech services and diagnostics-oriented companies
Event type fit: This is best described as a scientific and commercial hybrid event. It is not only a research conference; it is also a premium buying environment for technology, diagnostics, software, and service providers working in genomics and clinical genetics.
6️⃣ Estimated attendance / expected footfall
Estimated attendance: Typically several thousand attendees, often in the mid-to-high thousands depending on year, program scale, and host city accessibility.
Footfall quality: More important than raw volume is the quality of the audience. This event usually delivers:
- High density of specialist decision-makers
- Strong purchasing influence among lab, clinical, and research teams
- International diversity, especially across Europe
- Multiple commercial touchpoints through exhibition, posters, symposia, and networking sessions
Practical lead-gen value: Even if the total attendance is lower than a mass-market expo, the buyer intent and account value are typically much higher because attendees are directly involved in technology evaluation, research procurement, diagnostics adoption, or clinical service planning.
7️⃣ Key focus areas & buyer engagement
Key focus areas:
- Human genetics and genetic disease research
- Rare disease diagnostics and translational medicine
- Clinical genomics and precision medicine
- Sequencing technologies and workflow optimization
- Molecular diagnostics and assay development
- Bioinformatics, AI, and genomic data analysis
- Genetic counseling and clinical service delivery
- Laboratory automation and sample processing
- Population genomics and public health genetics
- Therapeutic development informed by genetics
Buyer engagement angle: Your outreach should focus on the exact pain points of the audience. Buyers at this event care about accuracy, turnaround time, workflow efficiency, sample integrity, interpretability, compliance, and clinical utility. Messaging should be positioned around research acceleration, diagnostic precision, and operational improvement rather than generic event attendance.
Best engagement examples:
- “Reach genomics and clinical genetics decision-makers evaluating sequencing, analysis, and diagnostic solutions.”
- “Connect with European research and hospital buyers in human genetics and precision medicine.”
- “Target institutions investing in rare disease, bioinformatics, and molecular diagnostics.”
8️⃣ Client-product fit note
Please share your client website before finalizing the exact buyer recommendation. The ideal buyer list changes depending on what your client sells.
Examples of how the best buyers shift by product:
- If your client sells sequencing instruments or genomic reagents, target genomics companies, hospital laboratories, research institutes, and molecular diagnostics teams.
- If your client sells software, data platforms, or AI tools, target bioinformatics leaders, clinical analytics buyers, digital health teams, and research informatics managers.
- If your client sells lab equipment or consumables, target lab directors, procurement managers, core facilities, and research operations teams.
- If your client sells consulting, clinical services, or outsourcing solutions, target biotech, pharma, hospitals, and diagnostic service providers.
What I need from you to refine the buyer list: Please send the client website or product page. Once I review it, I can narrow the target accounts, titles, and industry filters much more precisely for this event.
9️⃣ Final recommendation
This is a strong event for attendee-list selling if your client serves life sciences, genomics, diagnostics, healthcare research, or clinical innovation. It should be positioned as a high-value specialist conference rather than a mass market exhibition.
Best buyer segments to collect:
- Genomics and molecular diagnostics companies
- Hospital and clinical laboratory leaders
- Research institutes and university departments
- Biotech and pharmaceutical R&D teams
- Bioinformatics and health data solution buyers
- Precision medicine and rare disease stakeholders
Quality rating for B2B attendee-list sales: 9/10
This event offers highly relevant, technically qualified attendees with strong buying influence. The only caution is that the audience is specialized, so your success depends on matching the client product to the right sub-segment within genetics and genomics.
Next step: Share the client website, and I will review it and return the best buyer companies, titles, and industry filters tailored specifically to your client’s offer.
Data sheet
| Event Name | European Human Genetics Conference 2026 |
| Event Date | 13 June 2026 – 16 June 2026 |
| Event Status | Completed |
| Venue | Svenska Mässan |
| City | Gothenburg |
| State / Region | Västra Götaland County / West Sweden |
| Country | Sweden |
| Organizer | European Society of Human Genetics (annual conference series organizer; 2026 event-page confirmation recommended) |
| Official Event Website | eshg.org |
| Event Type | Scientific conference, medical congress, genomics and precision medicine meeting, clinical research and diagnostics networking event |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; IT & Technology |
| Audience Reach | Global, with strong European concentration |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. Historical conference-series scale and the user-provided event description indicate several thousand specialized delegates. |
| Attendance Data Reliability | Estimated / historical series-based assessment. Public confirmation for the 2026 edition was not located in the reviewed source set. |
| Main Purpose of Event | To convene the European and international human genetics community for scientific exchange, clinical genomics updates, diagnostics evaluation, research collaboration, rare disease discussion, precision medicine development, and supplier-buyer engagement across laboratory, software, sequencing, and translational medicine markets. |
The European Human Genetics Conference is a specialist annual meeting focused on human genetics, genomic medicine, molecular diagnostics, rare disease science, bioinformatics, and precision healthcare. It is positioned as a high-value scientific and commercial environment where academic researchers, clinical geneticists, hospital laboratories, biotech firms, pharma teams, and technology suppliers interact around emerging tools, data, and translational applications.
From a B2B perspective, the event matters because many attendees influence platform selection, laboratory purchasing, research partnerships, diagnostics adoption, software evaluation, and long-cycle enterprise buying decisions. It is especially relevant for organizations selling sequencing, laboratory instrumentation, sample-prep workflows, genetic testing services, bioinformatics platforms, data analytics, clinical software, and research support services.
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Clinical geneticists and genomic medicine physicians | University hospitals, regional genetics clinics, tertiary care centers | Influence diagnostic pathway decisions, test adoption, clinical workflow preferences | High relevance for clinical diagnostics, decision-support software, reporting tools, and interpretation platforms |
| Laboratory directors and molecular diagnostics leaders | Hospital labs, reference labs, national testing centers, academic core facilities | Own or shape purchasing of instruments, assays, LIMS, validation workflows, and service contracts | Priority buyer group for instrument vendors, reagent suppliers, automation providers, and lab software companies |
| Genomics researchers and principal investigators | Universities, institutes, consortia, translational research centers | Drive research platform selection, grant-led purchases, collaboration deals, and technology evaluations | Important for sequencing, data analysis, AI-enabled interpretation, and outsourced research services |
| Hospital procurement and sourcing stakeholders | Public health systems, university hospitals, diagnostics networks | Evaluate supplier contracts, framework agreements, compliance, and commercial terms | Essential for converting scientific interest into funded purchasing and approved vendor status |
| Biotech and pharma translational medicine teams | Biotechnology firms, pharmaceutical R&D units, companion diagnostics programs | Assess biomarkers, genomic datasets, assay partners, sample access, and precision medicine collaborators | High-value targets for research services, genomic analytics, CRO support, and companion diagnostic partners |
| Bioinformatics, data science, and clinical software leaders | Hospitals, genomic research centers, diagnostics companies, digital health teams | Select analytics pipelines, interpretation systems, cloud environments, and interoperability tools | Core audience for software, AI, cloud genomics, variant interpretation, and data governance solutions |
| Rare disease program leaders and registry managers | Hospitals, research alliances, patient-linked registries, nonprofit collaborations | Influence data collection systems, testing pathways, collaborative funding, and cohort partnerships | Relevant for patient data systems, diagnostics, registry tools, and translational partnerships |
| Technology transfer, partnerships, and innovation managers | Universities, institutes, biotech firms, incubators | Scout partnerships, licensing opportunities, platform collaborations, and commercialization channels | Useful for strategic alliances, co-development, and market-entry conversations |
| Association leaders, regulators, and guideline contributors | Scientific societies, healthcare bodies, standards groups | Shape standards, influence credibility, and affect procurement confidence indirectly | Important for policy awareness, trust-building, and scientific positioning |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Gothenburg | Local hospital, university, life science, and biotech participants | Medium | Host-city attendance likely includes nearby academic medicine and regional healthcare stakeholders |
| West Sweden / Västra Götaland | Regional universities, hospital systems, clinical labs, biotech firms | Medium | Regional reach supports local meetings, site visits, and account development in Swedish healthcare and life sciences |
| Nordics | Sweden, Denmark, Norway, Finland, Iceland genomics and healthcare research communities | High | Strong fit for Nordic reference labs, public health systems, rare disease programs, and academic centers |
| Europe | Broad attendance from EU and UK clinical genetics, diagnostics, academia, and biotech sectors | Very High | Primary buyer pool likely comes from European hospitals, universities, national genomic initiatives, and diagnostics ecosystems |
| International / Global | North America, Middle East, Asia-Pacific and multinational life science suppliers | Medium to High | Global relevance is likely, especially for sequencing, diagnostics, bioinformatics, pharma, and translational research partnerships |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | Although Europe is the core attendance base, the subject matter, supplier ecosystem, and scientific profile support international participation and cross-border buyer relevance. |
| National / Regional | Secondary reach description | The host location increases access for Swedish and Nordic clinical, research, and diagnostics stakeholders, strengthening local and regional account potential. |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Sahlgrenska University Hospital | University hospital / clinical genomics buyer | Host-city clinical and translational medicine institution with likely relevance for genetics, diagnostics, and lab technology engagement | sahlgrenska.se | Laboratory Director, Head of Clinical Genetics, Procurement Manager, Clinical Genomics Lead | Strong Market Fit, Attendance Not Confirmed |
| University of Gothenburg | Academic research institution | Host-city genomics, biomedicine, and clinical research relevance | gu.se | Professor of Genetics, Core Facility Director, Principal Investigator, Research Infrastructure Manager | Strong Market Fit, Attendance Not Confirmed |
| Karolinska Institutet | Medical university / research buyer | Leading Swedish medical research institution with genomics and translational medicine relevance | ki.se | Professor, Genomics Platform Head, Lab Director, Procurement Officer | Strong Market Fit, Attendance Not Confirmed |
| SciLifeLab | National life science infrastructure / core facility network | Highly relevant for sequencing, bioinformatics, omics platforms, and lab services | scilifelab.se | Platform Director, Facility Manager, Genomics Scientist, Research Infrastructure Lead | Strong Market Fit, Attendance Not Confirmed |
| Uppsala University | Academic buyer / research institution | Strong genomics and molecular medicine fit for instrumentation, software, and services | uu.se | Principal Investigator, Core Lab Manager, Department Head, Scientific Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| Lund University | Academic buyer / life sciences research institution | Relevant for clinical research, molecular diagnostics, and genomics infrastructure discussions | lu.se | Professor, Clinical Research Director, Lab Operations Manager, Bioinformatics Lead | Strong Market Fit, Attendance Not Confirmed |
| Genomics England | National genomics program / healthcare buyer | Relevant for genomic data platforms, clinical interpretation, and national-scale precision medicine procurement | genomicsengland.co.uk | Director of Genomics, Data Platform Lead, Partnerships Director, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| NHS Genomic Medicine Service | Public healthcare genomics buyer | Major buyer-side environment for clinical genomics tools, workflows, and diagnostic support systems | england.nhs.uk | Genomic Laboratory Director, Program Manager, Procurement Lead, Clinical Service Lead | Strong Market Fit, Attendance Not Confirmed |
| Charité – Universitätsmedizin Berlin | University hospital / diagnostics and research buyer | Large European clinical research and precision medicine institution | charite.de | Institute Director, Clinical Genetics Lead, Head of Molecular Diagnostics, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Erasmus MC | Academic medical center / clinical genomics buyer | Relevant for molecular diagnostics, precision medicine, and translational research procurement | erasmusmc.nl | Clinical Lab Director, Genomic Medicine Lead, Strategic Sourcing Manager, Research Program Director | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Laboratory Director | Laboratory Operations / Diagnostics | Director / Head | Often directly influences platform, assay, instrument, workflow, and service decisions |
| 2 | Head of Clinical Genetics | Clinical Services | Head / Director | Controls or strongly influences clinical test adoption and care pathway preferences |
| 3 | Director of Genomics / Genomics Program Lead | Genomics / Precision Medicine | Director / Program Lead | Relevant for strategic genomics infrastructure and data ecosystem decisions |
| 4 | Procurement Manager | Procurement | Manager | Converts technical interest into compliant commercial purchase processes |
| 5 | Strategic Sourcing Manager | Sourcing / Supply Chain | Manager | Important in hospital systems, academic institutions, and centralized purchasing environments |
| 6 | Principal Investigator | Research | Senior Individual Contributor / Faculty | Influences grant-funded purchases, collaborations, and research platform trials |
| 7 | Core Facility Director | Research Infrastructure | Director | High-value buyer for sequencing, automation, software, and service contracts |
| 8 | Bioinformatics Director / Head of Data Science | Bioinformatics / IT | Director / Head | Owns pipeline, storage, interpretation, and software evaluation decisions |
| 9 | Clinical Research Director | Clinical Research / Translational Medicine | Director | Key contact for biomarker programs, trial-enabling tools, and research services |
| 10 | Partnerships Director | Business Development / Alliances | Director | Useful for collaboration-led sales, data partnerships, and co-development opportunities |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core clinical buyer base for genetics and diagnostics | Clinical labs, hospital genetics departments, precision medicine programs |
| 2 | Research | Research institutes and translational genomics centers are central attendees | Platform evaluation, grant-driven purchases, data collaborations |
| 3 | Biotechnology | Biotech teams attend for genomic tools, biomarker work, and precision medicine | Research services, assay partnerships, software and analytics adoption |
| 4 | Pharmaceuticals | Precision medicine and companion diagnostics relevance | Biomarker strategy, translational research, genomic trial support |
| 5 | Medical Devices | Relevant for diagnostic hardware, lab systems, and clinical instrumentation | Lab equipment and clinical workflow procurement |
| 6 | Information Technology & Services | Bioinformatics, integration, and clinical software are important event themes | Data platforms, interoperability, interpretation software |
| 7 | Computer Software | Applicable to genomic analytics, AI, and reporting systems | Clinical interpretation, variant analytics, workflow orchestration |
| 8 | Higher Education | Universities and medical schools are major audience segments | Core facilities, research labs, consortium projects |
| 9 | Government Administration | Public healthcare and national genomics initiatives may participate or influence buying | Public health genomics programs, procurement, policy-linked initiatives |
| 10 | Health, Wellness & Fitness | Selective relevance for preventive genomics and personalized health solutions | Consumer-adjacent precision health and genomic service models |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Several thousand delegates | Estimated | Historical conference-series positioning and user-provided description | Attendance figure not publicly confirmed by the organizer in the reviewed source set |
| Exhibitor count | Not publicly confirmed | Unconfirmed | Public exhibitor figure not identified | Exhibitor volume is likely meaningful given conference profile, but no figure should be asserted without official confirmation |
| Buyer count | Not publicly confirmed | Unconfirmed | No public buyer program count located | This is a scientific/medical conference rather than a formal hosted-buyer show |
| Speaker count | Not publicly confirmed | Unconfirmed | Agenda count not verified in the reviewed source set | Likely extensive due to scientific program structure |
| Sponsor count | Not publicly confirmed | Unconfirmed | Sponsor listing not verified | Commercial ecosystem likely includes diagnostics, sequencing, software, and biotech suppliers |
| Historical attendance context | Strong international attendance, typically several thousand delegates | Historical / prior-year style characterization | User-provided description and established market positioning of the conference series | Use as directional planning input only, not as an organizer-certified metric |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Human genetics and genomic medicine | Accurate clinical interpretation and scalable genetics workflows | Clinical solution demos and evidence-based outcome discussions | Interpretation software, reporting tools, clinical genomics platforms |
| Molecular diagnostics | Validated assays, quality systems, throughput, reimbursement-readiness | Meet lab directors and translational teams evaluating diagnostic workflows | Assays, instruments, lab automation, QA tools, accreditation support |
| Rare disease research | Variant prioritization, cohort data, registry integration, patient pathway support | Collaboration-led sales with hospitals, research consortia, and nonprofit programs | Data platforms, diagnostics services, phenotype-genotype tools, registry software |
| Precision medicine | Clinical utility, biomarker strategy, companion diagnostics, data integration | Target translational medicine, pharma, and hospital innovation leaders | Decision support, biomarker analytics, companion diagnostic support |
| Sequencing and lab technology | Higher throughput, lower cost per sample, automation, reproducibility | Equipment-led lead generation with facility and purchasing stakeholders | NGS workflows, sample prep, automation, consumables, maintenance services |
| Bioinformatics and data analytics | Scalable analysis, secure storage, interoperability, reproducibility | Engage software buyers, IT leaders, and genomic data managers | Cloud platforms, AI analytics, LIMS, integration middleware, reporting systems |
| Clinical research and translational collaboration | Partner networks, sample access, validation studies, publication support | Useful for CROs, service labs, and partnership-oriented suppliers | Research services, trial support, biobanking, analytical validation |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Attendees are specialized and aligned with genomics, diagnostics, and precision medicine procurement or influence. |
| Decision-maker availability | High | Many attendees are scientific and operational decision-makers, though some purchases require institutional procurement follow-through. |
| Data collection potential | Medium | High-value audience, but public attendee disclosure may be limited because this is a scientific conference rather than an open retail expo. |
| Apollo targeting potential | High | Relevant accounts can be targeted through hospitals, universities, biotech, pharma, research institutes, and software buyers. |
| Geographic targeting potential | High | The event supports Nordic, European, and international outreach segmentation. |
| Best outreach approach | High | Use consultative messaging centered on clinical utility, throughput, validation, regulatory confidence, and research outcomes. |
| Overall lead quality | High | Strong event for specialized B2B pipeline building when the offer fits genomics, diagnostics, software, or translational research. |
| Best use case | High | Account-based outreach, exhibitor targeting, scientific commercial follow-up, and high-intent buyer profiling. |
| Limitations / risks | Medium | Public buyer-list transparency may be limited; some contacts are technical influencers rather than final budget owners. |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Research; Biotechnology; Pharmaceuticals; Medical Devices; Information Technology & Services; Computer Software; Higher Education; Government Administration | Capture the most likely clinical, research, and genomics technology buyers |
| Departments | Research, Operations, Engineering, Information Technology, Procurement, Clinical, Laboratory, Business Development | Focus outreach on both technical evaluators and commercial decision-makers |
| Seniority | Director, Head, VP, CXO, Partner, Manager, Professor-level leadership where searchable | Prioritize budget owners and strong technical influencers |
| Job titles | Laboratory Director; Head of Clinical Genetics; Director of Genomics; Clinical Genomics Lead; Core Facility Director; Bioinformatics Director; Principal Investigator; Molecular Diagnostics Manager; Procurement Manager; Strategic Sourcing Manager; Translational Medicine Director; Partnerships Director | Direct mapping to the event’s buyer and influence structure |
| Geography | Sweden, Denmark, Norway, Finland, Iceland, United Kingdom, Germany, Netherlands, Belgium, France, Switzerland, Austria, Spain, Italy | Align with Nordic host advantage and broader European conference reach |
| Employee size | 51-200; 201-500; 501-1,000; 1,001-5,000; 5,001-10,000; 10,001+ | Capture both scaling biotech buyers and large hospital or university systems |
| Keywords | genomics, human genetics, molecular diagnostics, precision medicine, rare disease, bioinformatics, NGS, sequencing, variant interpretation, clinical genomics, translational medicine, biomarker | Improve title and account relevance in Apollo prospecting |
| Technologies | Use where supported: cloud genomics, LIMS, sequencing analytics, AI diagnostics, healthcare data integration | Useful for software and platform vendors with technical fit |
| Revenue range | Mid-market to enterprise where available; public institutions may require title and organization filters instead | Helps prioritize larger funded buyers |
| Company type | Public hospitals, university medical centers, research institutes, biotech companies, pharma companies, health-tech providers | Keeps search aligned to real buyers rather than general attendees |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| European Society of Human Genetics (ESHG) | Official organizer / society website | Conference series ownership, event theme, society context | High for society-level verification; current-edition granular metrics should still be checked on the exact 2026 event page |
| Svenska Mässan | Official venue website | Venue identity and Gothenburg event-location validation | High |
| Gothenburg Official Visitor / City Information | Official destination source | City and regional context | Medium to High |
| User-provided event details and description | Input data | Dates, venue, city, country, event-theme framing, attendance context | Medium; used where primary-source current-edition detail was not available in the reviewed source set |
| Buyer-company websites listed in Section 4 | Official institutional websites | Institution legitimacy and market fit | High for organization existence; not evidence of 2026 attendance |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to European Human Genetics Conference 2026 — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.